Target intelligence / Profile preview

Bacterial deoxyribonucleic acid (Bacterial DNA) (DNA)

Target
DNA
Molecular classification
Nucleic acid
01

Overview

Bacterial deoxyribonucleic acid (DNA) is the primary carrier of genetic information in bacteria, typically organized as a single circular chromosome located in the nucleoid region, often accompanied by extrachromosomal plasmids (National Center for Biotechnology Information [NCBI], 2023). It serves as the template for DNA replication and RNA transcription, processes essential for bacterial growth, metabolism, and reproduction (StatPearls, Physiology, Bacteria, 2023). As a therapeutic target, bacterial DNA is exploited by several classes of antibiotics that achieve selective toxicity by targeting bacterial-specific enzymes or through the metabolic activation of prodrugs within the bacterial cell (PubMed, PMID: 25813469). For instance, fluoroquinolones inhibit DNA gyrase and topoisomerase IV, preventing the relaxation of supercoiled DNA and halting replication (StatPearls, Fluoroquinolones, 2023). Other agents, such as metronidazole, are reduced to reactive radicals that cause direct oxidative damage and strand scission of the DNA molecule (StatPearls, Metronidazole, 2023). While highly effective, drugs targeting bacterial DNA face significant challenges, including the rapid emergence of resistance through mutations in target enzymes or efflux pumps, and potential side effects such as the disruption of the host's healthy microbiome (Nature Reviews Microbiology, 2017).

Other names
Bacterial genomeBacterial chromosomeBacterial nucleic acidsPlasmid DNA
02

Mechanism of action

Inhibition of DNA topoisomerases (DNA gyrase and Topoisomerase IV) which prevents DNA supercoiling and replication, and the generation of reactive oxygen species or nitroso radicals that cause direct DNA strand scission (StatPearls, 2023; PubMed, PMID: 25813469).

03

Biological functions

Genetic information storageDNA replicationTranscriptionCell division
04

Disease associations

Infection
05

Safety considerations

Development of antimicrobial resistance (AMR)Disruption of the human microbiome (dysbiosis)Tendonitis and tendon rupture associated with fluoroquinolonesPotential for QTc prolongationCentral nervous system effects including seizures
06

Interacting drugs

Ciprofloxacin

6 more in the full profile.

07

Biomarkers

Bacterial DNA load (qPCR)Pathogen-specific DNA sequencesProcalcitonin

Beyond the preview

Go deeper on Bacterial deoxyribonucleic acid (Bacterial DNA) (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial deoxyribonucleic acid (Bacterial DNA) (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call